MICROBAC Trademark

Trademark Overview


On Monday, July 20, 2015, a trademark application was filed for MICROBAC with the United States Patent and Trademark Office. The USPTO has given the MICROBAC trademark a serial number of 86698323. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Monday, July 3, 2023. This trademark is owned by PROBIOTICAL S.P.A.. The MICROBAC trademark is filed in the Pharmaceutical Products category with the following description:

Micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation i...
microbac

General Information


Serial Number86698323
Word MarkMICROBAC
Filing DateMonday, July 20, 2015
Status701 - SECTION 8 - ACCEPTED
Status DateMonday, July 3, 2023
Registration Number4986679
Registration DateTuesday, June 28, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2016

Trademark Statements


Certificate of Correction for RegistrationIn the statement, line 19, "containing microorganisms and cultures of microorganisms" should be should be inserted after "products".
Goods and ServicesMicro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; Pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, including, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; Microbial and biological preparations for improving the physical well-being of humans, namely, reducing inflammation and pain; Supplements, namely, dietary supplements, for medical use and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; Supplements, namely, dietary supplements for medical use and baby food, all the above containing liquid, solid, dried or freeze-dried microorganisms or concentrated cultures of probiotic microorganisms; ferments for medical purposes, all the foregoing being for medical and veterinary use only
Pseudo MarkMICRO BACK

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 24, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePROBIOTICAL S.P.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressNovara (NO) 28100
IT

Party NamePROBIOTICAL S.P.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
Address28100 NOVARA
IT

Party NamePROBIOTICAL S.P.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
Address28100 NOVARA
IT

Trademark Events


Event DateEvent Description
Wednesday, January 13, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 26, 2016ASSIGNED TO LIE
Thursday, January 28, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 28, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 2, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, July 23, 2015NEW APPLICATION ENTERED
Friday, July 24, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 25, 2015NOTICE OF PSEUDO MARK E-MAILED
Thursday, October 29, 2015ASSIGNED TO EXAMINER
Friday, October 30, 2015NON-FINAL ACTION WRITTEN
Friday, October 30, 2015NON-FINAL ACTION E-MAILED
Friday, October 30, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 2, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, March 2, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, March 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 2, 2016ASSIGNED TO LIE
Tuesday, April 12, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 2, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 9, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 1, 2016SEC 7 REQUEST FILED
Tuesday, December 27, 2022TEAS SECTION 8 RECEIVED
Tuesday, April 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2016REGISTERED-PRINCIPAL REGISTER
Monday, August 1, 2016PAPER RECEIVED
Monday, October 31, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 31, 2016CORRECTION UNDER SECTION 7 - PROCESSED
Monday, June 28, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 10, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Tuesday, February 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 20, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 3, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, July 3, 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, December 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 10, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 10, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, December 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 10, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 8, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 8, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 8, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 8, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 8, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 28, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED